Search Results for "Adcirca"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Adcirca. Results 1 to 2 of 2 total matches.
See also: tadalafil

Phosphodiesterase-5 Inhibitors for Alzheimer's Disease?

   
The Medical Letter on Drugs and Therapeutics • Oct 31, 2022  (Issue 1662)
is also available as Revatio and tadalafil as Adcirca, Tadliq, and Alyq for treatment of pulmonary ...
A reader asked us to review use of the phosphodiesterase-5 (PDE5) inhibitor sildenafil for treatment of Alzheimer's disease (AD).
Med Lett Drugs Ther. 2022 Oct 31;64(1662):174-5 |  Show IntroductionHide Introduction

Sotatercept (Winrevair) for Pulmonary Arterial Hypertension

   
The Medical Letter on Drugs and Therapeutics • May 13, 2024  (Issue 1702)
once/day 57.60 Adcirca (Lilly) 4170.00 Alyq (Teva)7 56.60 Tadliq (CMP Pharma) 20 mg/5 mL susp ...
The FDA has approved sotatercept-csrk (Winrevair – Merck), a first-in-class activin signaling inhibitor, to increase exercise capacity, improve WHO functional class, and reduce the risk of clinical worsening events in adults with WHO Group 1 pulmonary arterial hypertension (PAH).
Med Lett Drugs Ther. 2024 May 13;66(1702):73-5   doi:10.58347/tml.2024.1702a |  Show IntroductionHide Introduction